Abstract | Mammalian cells respond to stress by activating mechanisms that support cellular functions and hence maintain microenvironmental and organismal homeostasis. Intracellular responses to stress, their regulation and their pathophysiological implications have been extensively studied. However, little is known about the signals that emanate from stressed cells to enable a coordinated adaptive response across tissues, organs and the whole organism. Considerable evidence has now accumulated indicating that the intracellular mechanisms that are activated in response to different stresses -which include the DNA damage response, the unfolded protein response, mitochondrial stress signalling and autophagy -as well as the mechanisms ensuring the proliferative inactivation or elimination of terminally damaged cells -such as cell senescence and regulated cell death -are all coupled with the generation of signals that elicit microenvironmental and/or systemic responses. These signals, which involve changes in the surface of stressed cells and/or the secretion of soluble factors or microvesicles, generally support systemic homeostasis but can also contribute to maladaptation and disease.
One of the reasons behind the evolutionary success of mammals (and other multicellular organisms) is their extraordinary capacity to adapt to changing environmental conditions. In over three decades of cell biology research, we obtained considerable insights into the molecular mechanisms whereby individual cells (attempt to) cope with perturbations of homeostasis. Such mechanisms of cellular adaptation to stress contribute to the formidable resilience of the organism but can also contribute to its degeneration over time, invariably culminating in ageing and/or disease 1 . Prominent examples of perturbations that induce cell stress include DNA-damaging agents (for example, ionizing radiation and some xenobiotics), which activate repair pathways specific for different types of genetic lesion 2 ; heat shock or chemical toxins that cause protein denaturation, both of which activate the unfolded protein response (UPR) in the endoplasmic reticulum (ER) and mitochondria 3, 4 ; hypoxia, respiratory poisons and xenobiotics that cause mitochondrial stress 5 ; nutrient deprivation, which activates autophagy in most cells of the organisms, hence enabling them to catabolize their own components for survival 6, 7 ; and infectious agents, which can drive a plethora of stress responses by activating pattern recognition receptors 8 . The triggers, receptors, signal transducers, effector mechanisms and adaptive responses that operate at the cellular level in each of these scenarios have been characterized in great molecular detail. As a common theme, it appears that perturbations of cellular homeostasis either lead to manage ment of stress and damage repair -generally along with transient alterations in cellular metabolismor culminate in cellular senescence or regulated cell death (RCD) when the restoration of normal cellular functions is impossible 9, 10 . The latter scenarios may be viewed as mechanisms for the preservation of organismal homeostasis, as severely damaged, irreversibly infected, functionless and/or potentially oncogenic cells are destined for persistent inactivation or elimination, respectively 11 . It has become apparent that most (if not all) mechanisms of cellular response to stress are also associated with paracrine and endocrine signals that communicate a potential threat to the organism and hence contribute to the maintenance of systemic homeostasis 1, [12] [13] [14] (Fig. 1 ).
This intercellular communication is achieved via multiple mechanisms, including (but not limited to) alterations in the shape of stressed cells and their connections with the microenvironment; the exposure of specific molecules on their surface; and the active or passive release of bioactive factors such as ions, small metabolites, intracellular proteins, cytokines or microvesicles.
Here, we review how distinct stress responses are relayed from the intracellular to the extracellular milieu, how such communication favours the maintenance of organismal homeostasis and how deviations from its normal course may drive maladaptation and disease.
Pattern recognition receptors
Evolutionarily conserved receptors that elicit inflammation and innate immunity upon recognition of conserved microbial products or endogenous danger signals.
Regulated cell death
(RCD). Variant of cell death that relies on a dedicated, genetically encoded machinery and hence can be delayed or accelerated with pharmacological or genetic interventions.
Adaptation to cellular stress Multiple potentially detrimental perturbations of the intracellular or extracellular microenvironment can be successfully managed by mammalian cells upon the activation of stress responses that preserve cellular functions and repair macromolecular damage.
The DNA damage response. DNA damage leads to the activation of cell cycle checkpoints coupled to the recruitment of the DNA repair machinery to genetic lesions. If the DNA damage response (DDR) is unsuccessful, the same machinery ultimately initiates cellular senescence or RCD 2 (Box 1), both of which also impinge on the control of microenvironmental and systemic homeo stasis (see separate sections below). Importantly, the DDR itself is also intimately connected with the elimination of damaged cells by immune effectors and the establishment of inflammatory responses that contribute to the maintenance of local and systemic homeostasis 15 . In some cases, however, such responses can favour maladaptation and contribute to the establishment of pathological conditions, especially in the presence of molecular defects in the mechanisms that physiologically extinguish inflammation 16 . DNA-damaging agents including ionizing radiation are known for their ability to change the immunogenicity of affected cells, hence facilitating their recognition by cytotoxic T lymphocytes (CTLs) or natural killer (NK) cells. Activation of the DDR has been linked to increased expression of major histocompatibility complex (MHC) class I molecules on the cell surface, resulting in increased susceptibility to recognition by CTLs. This increased recognition is particularly important for the elimination of malignant cells that express antigens potentially detectable by the immune system 17 . Moreover, DNA damage generally favours the upregulation of multiple ligands for NK cell activatory receptors, such as NKG2D type II integral membrane protein also known as KLRK1) and DNAX accessory molecule 1 (DNAM1; also known as CD226 (REFs 18, 19 )). The increased expression of these molecules is particularly relevant when genetic integrity cannot be restored, resulting in cell senescence 20 . In this context, NK cells remove cells with unrepairable DNA defects that would otherwise persist (although in a senescent, non-proliferative state) and potentially contribute to tissue deterioration and ageing (see below). Furthermore, accumulating evidence suggests that the DDR-mediated activation of NK cells contributes to the recognition and removal of pre-malignant and malignant cells and supports oncosuppression 21, 22 . Of note, NK cell-activating ligands can be shed by metalloproteinases secreted in the tumour microenvironment, resulting in the generation of decoy molecules that inhibit (rather than activate) NK cells 21 . DNA damage also initiates the secretion of soluble factors that regulate local inflammatory responses, both in the context of cellular senescence and independently of it. One of the mechanisms underlying this process involves the DNA damage-associated release of nuclear DNA fragments into the cytoplasm [23] [24] [25] [26] . Cytosolic DNA is recognized by cyclic GMP-AMP synthase (cGAS), which drives the activation of stimulator of interferon genes (STING; encoded by TMEM173) and the consequent production of type I interferon (IFN) 27, 28 . Because type I IFN is a strongly pro-inflammatory cytokine, its production needs to be tightly regulated to avoid tissue damage related to uncontrolled inflammation. Type I IFN secretion driven by cytosolic DNA recognition is negatively controlled by cytosolic nucleases, including three-prime repair exonuclease 1 (TREX1) and RNase H2 (REFs 29, 30 ) (Fig. 2a) . Accordingly, lossof-function mutations in TREX1 or any of the three subunits of RNase H2 (that is, RNASEH2A, RNASEH2B and RNASEH2C) have been associated with AicardiGoutières syndrome, an autoimmune disorder characterized by deregulated type I IFN production 27 . Of note, excessive cGAS-STING-dependent type I IFN secretion has also been involved in pathological maladaptation following myocardial infarction 31 . These observations exemplify how the deregulated release of type I IFN can contribute to disease.
That being said, production of type I IFN is critical for cancer immunosurveillance as it boosts the activity of multiple immune effector cells. To counteract this effect, cancer cells can upregulate TREX1 in response to DNA damage. Notably, high-dose irradiation -which potently induces TREX1 expression -is unable to drive type I IFN-dependent abscopal responses in mice, in contrast to hypofractionated irradiation, which does not induce TREX1 expression 25 . These observations can explain, at least in part, why hypofractionated irradiation exerts superior immunostimulatory effects and enhanced tumour control as compared with single high-dose radiation therapy in multiple preclinical settings 32, 33 . Ionizing irradiation and drugs that interfere with mitosis (such as the microtubular poison nocodazole) can also generate chromosome fragments or promote the missegregation of entire chromosomes, hence favouring the formation of micronuclei 23, 26 . A frequent event in micronuclei, the formation of which is favoured in the presence of RNase H2 defects 34 , is chromothripsis Chromothripsis is advantageous to progressing tumours as a source of clonal diversity (and hence cellular fitness) 36 . However, chromothripsis is also associated with the breakdown of the micronuclear envelope,
Immunogenicity
The ability to trigger an immune response, resulting from antigenicity (the property of being recognized by immune cells) and adjuvanticity (the property of delivering activating signals to immune cells).
Natural killer (NK) cells
A group of cells from the innate lymphoid immune system that can mediate cytotoxic functions independent of antigen recognition.
Major histocompatibility complex
(MHC). set of cell surface proteins essential for the immune system to recognize foreign molecules in vertebrates.
Abscopal responses
Measurable reductions in the size of a non-irradiated tumour or metastasis thereof following the irradiation of another lesion.
Hypofractionated irradiation
The delivery of radiation therapy in a few fractions, each with a larger dose than the standard 1.8 or 2 gy.
Micronuclei
small enveloped structures that encompass chromosomes of fragments thereof that are not incorporated into one of the daughter nuclei during mitosis.
Chromothripsis
A process whereby up to thousands of clustered chromosomal rearrangements occur in a single event in localized genomic regions affecting one or a few chromosomes.
which exposes DNA to the cytoplasm, followed by cGAS-STING activation, type I IFN secretion and consequent establishment of systemic immunity and immunosurveillance 23, 26 . Accordingly, the therapeutic effect of microtubule-targeting anticancer agents (such as taxanes) might be, at least in part, linked to their ability to provoke micronucleation and consequent type I IFN secretion 37 , whereas the clinical failure of other antimitotic drugs may reflect their inability to trigger this process 38 . Thus, cancer cells may benefit from the inactivation of cGAS, STING or their downstream effectors, including interferon regulatory factor 3 (IRF3) 39 . Of note, autophagy efficiently removes micronuclei [40] [41] [42] and hence might have an ambiguous role in tumour progression by avoiding chromothripsis (which would reduce the pace of clonal evolution) but at the same time suppressing micronuclei-driven type I IFN signalling (which would compromise immunosurveillance). Whether the autophagic degradation of micronuclei contributes to the well-established dual role of autophagy in tumour progression 43, 44 remains unresolved. Additional links between the DDR and systemic homeostasis have been elucidated in Caenorhabditis elegans. DNA damage in C. elegans germ cells drives the activation of MPK1, the worm orthologue of mammalian MAPK3 and MAPK1 (REFs 45 ), which causes the release of peptides that promote innate immunity response, followed by the activation of the ubiquitin-proteasome system in somatic tissues, enhanced proteostasis and systemic stress resistance 45 . In another study, localized exposure of nematodes to ultraviolet light to induce DNA damage was shown to trigger a systemic stress response that was dependent on cep-1, the orthologue of mammalian TP53 (encoding p53), and on cpr-4, the orthologue of mammalian CTSB (encoding cathepsin B). In this case, local activation of CEP-1 promoted expression and secretion of CPR-4 into the extracellular fluids and into the culture medium. CPR-4 release was associated with reduced cell death in the non-irradiated tissues and neighbouring animals, as well as with larval lethality. Subsequently, CPR-4 was mechanistically identified as the factor responsible for these radiation-induced bystander effects 46 . This mechanism is an interesting example of intracellular adaptation to stress relaying a signal not only to the entire organism but also to other individuals. It remains to be seen whether extracellular CTSB (which is normally confined within lysosomes) also participates in the bystander effects of radiation in mammals. Of note, extracellular CTSB has been documented in human neoplasms 47 and may influence tumour progression as well as responses to treatment 48, 49 . Intriguingly, in mice, monkeys and humans, circulating CTSB levels are increased in response to exercise. In this context, CTSB was shown to act as a myokine that is required for the running-stimulated increase in adult hippo campal neuro genesis and spatial memory function 50 . Thus, CTSB may have multiple paracrine and endocrine effects in mammals as well. Whether CTSB secretion in mammals involves the DDR remains an open question.
Altogether, these examples illustrate some of the mechanisms through which the DDR can initiate paracrine and endocrine signals with adaptive (or maladaptive) consequences. To what degree the type and the extent of DNA damage influence these processes remains to be clarified. Moreover, it remains unclear whether there is a minimal degree of damage that is required to raise the systemic response and to what extent the intracellular output of the DDR (DNA repair) and its extracellular effects (paracrine and endocrine signalling) are coupled.
The unfolded protein response. The UPR operating at the ER, also known as UPR ER , is an adaptive response aimed at resolving the accumulation of unfolded polypeptides in the ER lumen or eliminating cells that cannot recover reticular proteostasis by inducing RCD 3 (Box 2). In conjunction, the UPR ER is able to initiate inflammatory responses that -if unresolvedcontribute to pathogenic maladaptation, metabolic disorders and accelerated ageing 51 . For instance, renal epithelial cells subjected to ER stress secrete angiogenin (ANG) as a consequence of the activation of inositolrequiring enzyme 1α (IRE1α; encoded by ERN1) and nuclear factor-κB (NF-κB) signalling, which favours the establishment of inflammation by tissue-resident macrophages 52 . Similarly, hepatocytes responding to ER stress secrete hepcidin antimicrobial peptide (HAMP) following the UPR ER -dependent activation of cAMPresponsive element-binding protein 3-like protein 3 (CREB3L3) 53 . Circulating HAMP ultimately causes hypoferraemia and splenic iron sequestration in mice 53 . This mechanism links the UPR ER in a specific nATure revIeWS | MolECUlAR CEll BIology If microenvironmental fluctuations are too intense or prolonged for cellular adaptation, however, mammalian cells actively undergo either senescence, resulting in their permanent proliferative inactivation, or regulated cell death (RCD), resulting in their elimination. Both cellular senescence and RCD constitute mechanisms for the preservation of systemic homeostasis when physiological cellular functions are terminally lost. Moreover, cellular adaptation to stress (be it successful, leading to damage repair and recovery , or not successful, leading to proliferative inactivation or elimination) is intimately linked to cell-extrinsic mechanisms that operate locally or systemically in support of organismal homeostasis. Thus, cellular responses to potentially threatening perturbations are efficiently relayed to the local and systemic microenvironment via a large panel of danger signals that operate as paracrine or endocrine mediators to promote the maintenance of organismal fitness.
Proteostasis
The maintenance of protein homeostasis within a defined organelle, cell or tissue, which involves correct protein synthesis, folding, distribution and degradation.
Myokine one of several small proteins or proteoglycans that are released by myocytes upon contraction to mediate autocrine, paracrine or endocrine effects.
Nuclear factor-κB (NF-κB) signalling Biological output of NF-κB-dependent transcription, generally involving a robust pro-inflammatory component.
Hepcidin antimicrobial peptide
(HAMP). Key negative regulator of circulating iron availability in mammals, promoting a state of accrued bacterial resistance. compartment (the liver) with organismal iron homeostasis, specifically with a reduction in systemic iron that mediates antibacterial effects (Fig. 2b) .
Induction of RCD by the UPR ER is mainly driven by deregulated protein synthesis, which results from the activation of C/EBP-homologous protein (CHOP; also known as DDIT3). CHOP is a target of activating transcription factor 4 (ATF4; one of the main UPR ER effectors; see Box 2) and transactivates several genes involved in translation 3 . In cells that are susceptible to ER stress, such as intestinal epithelial cells (IECs), CHOP also transactivates genes coding for NKG2D ligands such as UL16-binding protein 1 (ULBP1), potentially driving a spontaneous intestinal inflammation (enteritis) consequent on local NK cell activation 54 . Thus, the UPR ER resembles the DDR in its ability to promote the restoration of cellular homeostasis or, when this is not possible, to drive RCD along with the activation of local inflammation and innate immunity.
Interestingly, ectopic activation of ATF4 in the skeletal muscle by means of a ligand-activated variant of PKR-like ER kinase (PERK; also known as EIF2AK3; see Box 2) expressed under the control of a tissue-specific promoter drives the secretion of fibroblast growth factor 21 (FGF21), an anti-obesity myokine 55 . This finding may explain how muscle-specific PERK activation stimulates energy consumption by the brown adipose tissue, hence limiting weight gain in mice receiving a high-fat diet 55 . Interestingly, the PERK-ATF4-FGF21 axis may also be activated by chronic exercise and exposure to cold temperatures, two conditions that promote UPR ER in the skeletal muscle 55, 56 . This process exemplifies the endocrine pathways whereby the skeletal muscle affects systemic metabolism. It will be interesting to see whether myokine signalling can be targeted for the treatment of metabolic disorders in humans.
Multiple tissues from obese individuals, including the liver, abdominal fat and hypothalamus, show signs of ER stress, including the phosphorylation of PERK and another UPR ER effector, eukaryotic translation initiation factor 2 subunit-α (eIF2α; also known as EIF2S1; see Box 2)
57
. There is now evidence that such an adiposity-associated UPR ER could potentially contribute to alleviating pathogenesis of the disease. For example, conditional deletion of the UPR ER effector Xbp1 (see also Box 2) from neurons and glia increases the susceptibility of mice to diet-induced obesity as it causes severe resistance to the satiety hormone leptin 57 . Conversely, overexpression of spliced XBP1 (XBP1s) in specific hypothalamic neurons contributes to improved hepatic insulin sensitivity and suppression of endogenous glucose production in mice on a high-fat diet 58 . These metabolic effects are mediated by a brainto-liver communication and are associated with UPR ER activation in hepatocytes, which contributes to metabolic health by triggering a transcriptional programme that mimics the postprandial status 58 . The precise mediators of this endocrine propagation of the UPR ER remain unknown. Intriguingly, in C. elegans, neuronal expression of XBP1s extends lifespan by stimulating the UPR ER in intestinal cells. This pathway involves the release of neurosynaptic vesicles from neurons, suggesting that in this setting the mediator of endocrine UPR ER induction is a neurotransmitter 59 . It has been speculated that the programme elicited by neuronal XBP1s may deliver pre-emptive signals to peripheral tissues to stimulate a systemic stress response preparing the organism for coping with stress 51 . However, this hypothesis remains to be experimentally validated.
Of note, in some instances (for example, in ageing mammalian cells) the ability of the UPR ER machinery to efficiently resolve ER stress or drive RCD is limited, resulting in the establishment of chronic ER stress, which is a major determinant of immunological, neurological and metabolic maladaptation 51 . Thus, although the acute UPR ER generally supports microenvironmental and systemic homeostasis by favouring cellular adaptation to ER stress or RCD, its chronic counterpart has detrimental effects for the organism 51, 60, 61 .
Activation of the UPR
ER is also prominent in cancer cells as a mechanism to cope with intense protein synthesis associated with high proliferation rates and in response to microenvironmental inducers of ER stress (for example, some chemotherapeutics, see below) 3 . Importantly, the UPR ER can be relayed from malignant cells to myeloid cells by thus-far unidentified sol uble factors, resulting in the secretion of multiple proinflammatory cytokines, including interleukin 6 (IL-6) and tumour necrosis factor (TNF) 62 . Such a transmissible ER stress (TERS) also operates between cancer cells, leading to the exposure of the ER chaperone BiP (also known
Brown adipose tissue
Highly specialized adipose tissue, the main function of which is to produce heat (thermogenesis).
Box 1 | The DNA damage response at a glance nuclear DnA can be damaged by external cues (for example, ultraviolet light and xenobiotics) and by endogenous causes, including errors in DnA replication or DnA maintenance. The term DnA damage response (DDr) generally refers to a highly interconnected network of molecular pathways that is in place to sense and manage specific genetic lesions as they form. Similar to most cellular mechanisms of adaptation to stress, the DDr can enable tolerance of damage, repair or the permanent inactivation (via cellular senescence or regulated cell death (rCD)) of cells bearing non-tolerable or non-repairable lesions.
There are multiple pathways whereby the DDr initially attempts to repair DnA damage, including (but not limited to) base excision repair (ber), which operates on DnA lesions that do not impose large distortions to the DnA double helix; nucleotide excision repair (ner), which corrects a broad panel of DnA lesions, including adducts and other bulky structures that distort the double helix; DnA mismatch repair (MMR), which resolves base mismatches as well as small insertions or deletions; nonhomologous end-joining (nHeJ), which is the main pathway whereby mammalian cells fix double-strand breaks (DSbs); and homologous recombination (Hr), which also repairs DSbs but is active only in the S and G2 phases of the cell cycle 180 . moreover, socalled translesion synthesis (TlS) bypasses, but does not remove, DnA lesions that stall the replication machinery and would otherwise cause its collapse or introduce DSbs. of note, TlS is a major mechanism of tolerance to DnA damage and is generally associated with an increased mutational rate as compared with conventional DNA replication.
Two major players in the DDr of mammalian cells are ataxia telangiectasia mutated (ATm) and ataxia telangiectasia and rad3-related protein (ATr). upon recruitment to damaged DnA via dedicated supramolecular platforms, ATm and ATr phosphorylate, hence activating, a wide panel of factors involved in the preservation of nuclear and extranuclear homeostasis, including histone H2AX, checkpoint kinase 2 (CHeK2) and CHeK1, which culminates with the stabilization of tumour suppressor p53. Initially, p53 supports repair mechanisms by transactivating genes that enable a reversible cell cycle arrest and maintain metabolic homeostasis. However, if genetic lesions cannot be resolved, p53 acquires the ability to efficiently drive cellular senescence or rCD via transcriptional and transcription-independent mechanisms 180 . Thus, p53 stands at a crucial position in the molecular mechanisms that determine whether DnA lesions can be repaired (coupled to the restoration of cellular homeostasis) or not (coupled to the proliferative inactivation or elimination of damaged cells in support of organismal homeostasis).
as HSPA5 and GRP78) on the cell surface, an IRE1α-dependent increase in WNT signalling and the activation of the PERK-ATF4 axis, which collectively provide cytoprotection and promote cancer growth. Accordingly, TERS-primed cancer cells grow more quickly in vivo than their control counterparts 62 . Some cell-deathpromoting chemotherapeutic agents such as anthracyclines and oxaliplatin also trigger a partial ER stress response in cancer cells, which manifests with PERKdependent eIF2α phosphorylation but not with ATF4, ATF6 and XBP1s activation 63 . Phosphorylated eIF2α favours the translocation of ER chaperones including calreticulin (CALR) and protein disulfide-isomerase A3 (PDIA3) from the ER lumen to the cell surface 64 , where they act as 'eat-me' signals to promote phagocytosis of dying cancer cells by dendritic cells and hence initiate anticancer immunity 17 . The clinical relevance of this process is supported by the fact that CALR exposure on cancer cells correlates not only with eIF2α phosphorylation but also with prognostically favourable anticancer immune responses 65, 66 . Of note, dying cancer cells can also release soluble CALR, which limits the ability of macrophages to present phagocytosed antigens (as a consequence of MHC class II downregulation) 67 and favours the accumulation of myeloidderived suppressor cells (MDSCs) 68 , hence potentially promoting tumour progression. Thus, the net microenvironmental effect of UPR ER -driven CALR signalling may depend on the balance between the surface-bound and soluble variants of the molecule. This finding is reminiscent of the DDR-driven exposure of NK-cell-activating ligands on the surface of cancer cells, which upon Fig. 2 | The DDR and UPR ER in the regulation of microenvironmental and systemic homeostasis. a | DNA damage in mammalian cells can cause the activation of a transcriptional response driven by nuclear factor-κB (NF-κB), culminating with the exposure of major histocompatibility complex (MHC) class I molecules on the cell surface. In conjunction, the detection of genetic lesions by ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related protein (ATR) can stimulate the exposure of natural killer (NK) cell-activating ligands (NKALs) on the outer leaflet of the plasma membrane. Both of these processes facilitate the recognition of cells experiencing DNA damage by lymphoid cells. Moreover, multiple DNA-damaging agents cause the release of double-stranded DNA (dsDNA) into the cytosol or the formation of micronuclei, ultimately leading to type I interferon (IFN) secretion mediated by the activation of cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Upon binding to heterodimeric IFNα/β receptors (IFNARs) on myeloid cells, type I IFN stimulates local inflammation. b | Activation of the unfolded protein response (UPR) operating at the endoplasmic reticulum (ER), also known as the UPR ER , in hepatocytes has been linked to the transactivation of hepcidin antimicrobial peptide (HAMP) following cAMP-responsive element-binding protein 3-like 3 (CREB3L3) activation. The consequent increase in circulating HAMP enables the sequestration of iron in the spleen upon the HAMP-dependent inhibition of solute carrier family 40 member 1 (SLC40A1) on splenocytes. This reduction in iron availability contributes to the systemic antibacterial response, as bacteria rely on iron uptake for growth. CHK , checkpoint kinase; DDR , DNA damage response; IRF3, interferon regulatory factor 3; NKG2D, NKG2D type II integral membrane protein; TCR , T cell receptor ; TREX1, three-prime repair exonuclease 1.
Dendritic cells
Myeloid cells that play a major role in the initiation of T celldependent immune responses.
Myeloid-derived suppressor cells (MDsCs) . A heterogeneous population of cells that are defined by their myeloid origin, immature state and ability to potently suppress T cell responses.
solubilization by metalloproteinases inhibit cancer recognition by NK cells (see above). Overall, although the UPR ER in living malignant cells mostly promotes cancer growth by cell-intrinsic and cell-extrinsic mechanisms, the UPR ER coupled to cancer cell death generally stimulates anticancer immunity.
In summary, there are multiple pathways whereby the UPR ER is relayed to other cells and tissues, many of which occur in the context of human disease. Interestingly, although the cellular output of the UPR ER (recovery of ER homeostasis or RCD activation) almost invariably involves the three arms of the process (Box 2), the same does not always apply to UPR ER -driven paracrine and endocrine signalling. Therefore, it is tempting to speculate that one or more branches of the UPR ER may have evolved specifically to link intracellular response to stress with organismal homeostasis. This possibility remains to be experimentally investigated.
Mitochondrial stress signalling. The accumulation of unfolded proteins in the mitochondrial matrix drives a variant of the UPR (commonly referred to as UPR mt ), which resembles the UPR ER in its general organization -namely, the activation of a broad transcriptional response aimed at the restoration of mitochondrial proteostasis [69] [70] [71] . Although they share some signal transdu cers and effectors (see below), the UPR mt and the UPR ER should be considered as two distinct processes, not only because they respond to stress at two different cellular compartments but also because they have cellular, local and systemic consequences that only partially overlap 51, 72 . Of note, UPR mt is an evolutionarily conserved process, and UPR mt -like responses have been documented in multiple eukaryotes other than mammals, including plants, flies and nematodes [72] [73] [74] . In C. elegans, the UPR mt can be relayed across the organism to trigger a distant UPR mt in the intestine, which is coupled to a positive effect on lifespan 75 . Such a systemic propagation of the UPR mt requires a defined subset of sensory neurons and interneurons as well as several neurotransmitters, including serotonin, that operate in a complex circuitry 75, 76 . How these signalling systems connect to each other has not yet been determined. Intriguingly, the UPR mt caused by pathogen invasion (via hitherto unclear mechanisms) in C. elegans cells is connected to the transactivation of genes coding for antimicrobial peptides through the stress-activated transcription factor ATFS-1 (REF. 77 ). This observation is reminiscent of the relationship between CHOP (the putative mammalian orthologue of ATFS-1) 78 and innate immune responses in mammalian intestine resulting from the activation of UPR ER (see above) 72 , suggesting that intracellular responses to stress became connected to organismal homeostasis rather early during evolution.
In mammalian cells, the UPR mt is part of the socalled integrated stress response; involves ATF4, ATF5, CHOP and CCAAT/enhancer-binding protein-β (C/EBPβ) 4 ; and is associated with a metabolic switch to glycolysis that favours mitochondrial repair 79 . Similar to the UPR ER , the UPR mt is also relayed across the plasma membrane to initiate local and systemic adaptation to stress, a process that largely depends on mitokines 4,70 , including nuclear-encoded FGF21 (which is also secreted as a consequence of the UPR ER ) and growth differentiation factor 15 (GDF15). FGF21 produced by skeletal muscle cells in response to mitochondrial dysfunction -which occurs in an ATF4-dependent manner -increases lipid catabolism and promotes mitochondrial biogenesis and browning in adipocytes 80 . Along similar lines, secretion of GDF15 by skeletal muscle cells undergoing the UPR mt affects systemic metabolism, whereby GDF15 improves insulin sensitivity by enhancing oxidative metabolism and lipid mobilization in the adipose tissue, liver and muscle 81 . Of note, weight loss induced by GDF15 depends on its cognate receptor GDNF family receptor α-like (GFRAL) 82 . GFRAL is expressed in the area postrema of the brainstem, an area that participates in the control of satiety and is the only part of the brain outside of the blood-brain barrier 82 . In line with its links to mitochondrial stress, circulating GDF15 has been proposed as a biomarker for mitochondrial dysfunction in ageing and age-related disorders 83 . Moreover, GDF15 levels are increased in obese individuals 84 . However, somewhat paradoxically GDF15 can be used to treat obesity in multiple organisms, including . In mammalian cells, the acute phase of the uPr er involves three different signalling modules: the activation of PKr-like er kinase (PerK) and consequent phosphorylation of eukaryotic translation initiation factor 2 subunit-α (eIF2α), ultimately resulting in a global rearrangement of translation that limits the synthesis of the majority of proteins but enables expression of activating transcription factor 4 (ATF4); the activation of ATF6 and its translocation from the er to the nucleus via the Golgi apparatus; and the activation of inositol-requiring enzyme 1α (Ire1α) and consequent alternative splicing of X-box binding protein 1 (XbP1) to generate the active variant of the protein, spliced XbP1 (XbP1s) 3, 51 . ATF4, ATF6 and XbP1s act as transcription factors that initially control the expression of genes involved in the mechanisms of homeostatic adaptation to protein overload, including an increased capacity for protein folding and chaperoning within the er and an increased flux of protein degradation via the proteasome and autophagy 3, 51 . one of the main regulators of the uPr er is an er chaperone biP (also known as HSPA5 and GrP78) 3, 51 , which inhibits PerK, ATF6 and Ire1α activation in physiological conditions. unfolded proteins accumulating in the er lumen compete for BiP binding with PERK, ATF6 and IRE1α, ultimately leading to uPr er activation. Of note, the gene encoding BiP, HSPA5, is transactivated by ATF4, ATF6 and (less so) XbP1s [181] [182] [183] , and the HSPA5 mrnA can be normally translated even in the context of eIF2α phosphorylation owing to an internal ribosome entry site 184 . Thus, biP operates within a negative feedback circuitry that attempts to shut down the uPr er upon restoration of homeostatic conditions 3, 51 . If reticular proteostasis cannot be recovered, however, prolonged uPr er signalling triggers (generally apoptotic) regulated cell death (rCD) following the ATF4-driven activation of C/ebP-homologous protein (CHoP). Among various target genes, CHoP transactivates protein phosphatase 1 regulatory subunit 15A (PPP1r15A), which, in complex with serine/threonine-protein phosphatase PP1α catalytic subunit (PP1A), catalyses the dephosphorylation of eIF2α, resulting in high protein synthesis despite persistent protein folding overload 3, 185 . In addition to augmenting er stress, this enables the translation of multiple mRNAs upregulated by CHOP that code for proapoptotic factors, including those that encode bCl-2 binding component 3 (BBC3), bCl-2-interacting mediator of cell death (bIm; encoded by BCL2L11) and tumour necrosis factor receptor superfamily member 10b (TNFRSF10B) 186, 187 . Thus, at the cell-intrinsic level, the acute phase of the uPr er operates as a conventional adaptive response to stress as it initially attempts to restore cellular homeostasis but elicits rCD if cellular functions are irremediably compromised 3, 51 . rodents and non-human primates 85 . Thus, the elevation of circulating GDF15 documented in the course of obesity may reflect a physiological compensatory mechanism to obesity-associated mitochondrial dysfunction and insulin resistance that is, however, insufficient to affect body mass. Overall, FGF21 and GDF15 exemplify factors that connect intracellular stress (for example, mitochondrial dysfunction) to the regulation of systemic processes (lipid metabolism and eating behaviour, in this specific case) via endocrine mechanisms (Fig. 3a) .
Integrated stress response
Some mitochondrial DNA (mtDNA)-encoded peptides also act as mitokines, although their actual link with the UPR mt remains to be elucidated. These peptides, which are generally encoded by small, alternative reading frames of the mitochondrial genome, include humanin, multiple small humanin-like peptides (SHLPs) and mitochondrial-derived peptide MOTSc (also known as MTRNR1) 86 . Humanin not only favours proteostasis and has broad cytoprotective effects coupled to the activation of multiple variants of autophagy 87, 88 but also may be involved in the regulation of systemic glucose homeostasis 89 . Along similar lines, MOTSc has been attributed a robust role in the preservation of organismal metabolic homeostasis, most likely reflecting its ability to trigger AMP-activated protein kinase (AMPK) activation in the skeletal muscle 90 . Of note, exogenously administered MOTSc appears to boost the ability of mice to control methicillin-resistant Staphylococcus aureus infection as a consequence of enhanced bactericidal functions by macrophages 91 . Thus, some mitokines may have immuno modulatory effects that participate in the control of systemic homeostasis during infection. SHLP2 also resembles humanin in its cytoprotective effects and its ability to support glucose homeostasis 92 . The biological effects of other SHLPs remain to be explored.
Mitochondrial stressors other than the accumulation of unfolded proteins (for example, respiratory chain poisons) and several other perturbations of cellular homeostasis can culminate in mitochondrial outer membrane permeabilization (MOMP), which is generally an irreversible step in the cascade of events leading to apoptosis 10 . However, MOMP affecting a minority of mitochondria does not necessarily drive RCD but robustly relays intracellular stress to the local and systemic microenvironment 93 . The release of mtDNA into the cytosol following MOMP drives cGAS-STING-dependent type I IFN production 94, 95 , as well as inflammasome activation 96 , hence favouring the establishment of local inflammation. This process is limited by the proficient removal of damaged mitochondria by autophagy (mitophagy) 97, 98 and is negatively controlled by caspase 3 (CASP3) 94, 95 . Upon binding to GDNF family receptor α-like (GFRAL) on the surface of neurons of the area postrema of the brainstem, circulating GDF regulates eating behaviour. Blood-borne FGF21 modulates lipid metabolism in the adipose tissue, a process that largely depends on FGF receptor 1 (FGFR1). b | Autophagy-dependent ATP secretion by living cancer cells has been linked to the activation of purinergic receptor P2X7 (P2RX7) in the context of autocrine or paracrine circuitries that stimulate tumour progression. Conversely , the release of ATP by cancer cells that mount unsuccessful autophagic responses to treatment and hence undergo cell death is critical for the recruitment of myeloid cells to the tumour microenvironment, a process that depends on purinergic receptor P2Y2 (P2RY2), and myeloid cell activation, which relies on P2RX7. ATF4, activating transcription factor 4.
Mitochondrial reactive oxygen species, which are overproduced in response to various stresses, not only favour inflammasome activation and the consequent inflammatory response 99 but also contribute to the optimal transactivation of vascular endothelial growth factor A (VEGFA) driven by hypoxia, orchestrating microenvironment adaptation to decreased oxygen availability via neovascularization 100 . Finally, cardiolipin, a phospholipid that is normally restricted to mitochondrial membranes, can be presented by CD1D molecules on the cell surface to γδ T lymphocytes, resulting in their activation 101 . However, it remains unclear whether cardiolipin presentation can occur in the context of intracellular adaptation to stress or only following induction of RCD.
Thus, it is clear that mitochondrial stress is communicated to the local microenvironment and the whole organism by a multitude of mechanisms. Interestingly, the UPR mt exhibits multiple similarities with its ER counterpart, including the ability to trigger FGF21 secretion in an ATF4-dependent manner. This observation suggests that (at least part of) the adaptive mechanisms triggered by loss of cellular proteostasis originate at highly dynamic platforms that tether subdomains of the ER to mitochondria, which are commonly known as mitochondria-associated ER membranes (MAMs) 102 . Additional work is required to elucidate this possibility.
Autophagy. Autophagy, in many of its variants (Box 3), has recently emerged as one of the most central mechanisms of adaptation to stress across the eukaryotic kingdom, representing a promising (yet complex) target for the treatment of multiple human disorders 103, 104 . In particular, macroautophagy (hereafter referred to as autophagy) degrades potentially harmful or disposable cytoplasmic entities to support cellular homeostasis in physiological conditions as well as during adaptation to stress 6 . Beyond this phylogenetically conserved cell-autonomous cytoprotective effect, autophagy has a variety of microenvironmental and systemic outcomes, which have been demonstrated by elegant studies in which the deletion of core components of the autophagic machinery in specific cells was shown to affect pathophysiological processes in other cells. However, the interpretation of such studies is complicated by the fact that individual components of the autophagic appar atus may have autophagy-unrelated functions. Thus, only studies in which the individual inactivation of several different core constituents of the autophagic machinery yields a similar phenotype should be interpreted as an indication that the phenomenon under scrutiny is indeed caused by an autophagy defect (as opposed to a defect in an autophagy-related process) 7 .
In some cases, the extracellular effects of autophagy are linked to local or systemic metabolism 105 . For instance, cancer-associated fibroblasts provide lactate and ketone bodies to breast cancer cells in an autophagydependent manner 106 . Similarly, pancreatic stellate cells support the progression of pancreatic adenocarcinoma cells by releasing alanine upon activation of autophagy 107 .
In these settings, autophagic responses are likely to be driven by the harsh conditions that generally characterize the tumour microenvironment (for example, low nutrient availability and hypoxia) 43 . Autophagy also supports the secretion of ATP from both living and dying cells, which has major microenvironmental effects. For example, ATP secreted by living melanoma cells in an autophagydependent manner promotes tumour progression via autocrine and paracrine mechanisms 108 . However, in the context of RCD, the release of ATP can drive the recruitment of myeloid cells to apoptotic bodies, which is particularly relevant for cell corpse removal during developmental tissue remodelling 109 and for anti cancer therapy, when the release of ATP by dying cancer cells recruits and activates dendritic cells to initiate tumour-targeting immune responses 17, 110, 111 (Fig. 3b) . Multiple strategies are currently being tested to pharmacologically target the signalling pathways driven by extracellular ATP, especially in the context of cancer therapy 112, 113 . Finally, proficient autophagic responses in the liver, skeletal muscle, adipose tissue and pro-opiomelanocortin neurons prevent pathological weight gain and maintain optimal glucose homeostasis throughout the organism via endocrine pathways that remain to be fully elucidated 13, 114 . Thus, the local and systemic effects of autophagy induction on metabolism and immune functions have major implications for human pathophysiology.
Autophagy is also required for a form of nonconventional secretion that involves proteins such as interleukin-1β (IL-1β) (REF.
115
) and the diazepam-binding γδ T lymphocytes T cells expressing a γδ (rather than an αβ) T cell receptor, which is associated with a fairly limited antigenic repertoire but major histocompatibility complex-independent recognition.
Cancer-associated fibroblasts
Fibroblasts that are found in the tumour microenvironment and generally support malignant cells by nutritional and immunological mechanisms.
Ketone bodies
Three related compounds (acetone, acetoacetic acid and β-hydroxybutyric acid) that are produced during the metabolism of lipids.
Stellate cells
Hepatic or pancreatic cells that have a major role in the establishment and maintenance of fibrosis.
Box 3 | Autophagy at a glance
The word autophagy refers to a group of mechanisms that deliver superfluous or potentially dangerous cytoplasmic entities (be they of endogenous or exogenous origin) to the lysosome for degradation. There are at least three different variants of the process: microautophagy, in which the cargo is directly internalized in small vesicles that form at the surface of the lysosome (vacuole in yeast) or late endosomes; chaperone-mediated autophagy, in which proteins bearing one or multiple KFerQ-like motifs are recognized by heat shock protein family A (Hsp70) member 8 (HSPA8) and translocated across the lysosomal membrane by a specific splicing variant of lysosomal associated membrane protein 2A (lAmP2A); and macroautophagy, in which the materials destined for degradation are progressively sequestered by a dedicated double-membrane organelle (the autophagosome), which eventually fuses with the lysosome to generate a so-called autolysosome 7 . ultimately, lysosomal hydrolases are activated by lysosomal acidification, leading to degradation of the autophagic cargo and recycling of the autophagic products back to the cytoplasm to feed bioenergetic metabolism or repair pathways. macroautophagy, which is the best-characterized variant of autophagy in mammalian cells, can be unselective (degrading various disposable components in support of general bioenergetic homeostasis) or can target a specific substrate as part of a very selective response to stress (for example, permeabilized mitochondria, protein aggregates or invading pathogens) 188 . The targeted delivery of a substrate to autophagosomes for degradation is generally ensured by autophagy cargo receptors 189 . Importantly, virtually all eukaryotic cells exhibit constitutive autophagic flux in physiological conditions. This constant autophagic activity is paramount for the preservation of homeostasis as it ensures the removal of the by-products of normal cellular functions and promotes physiological organelle turnover. In addition, autophagic degradation increases in response to a variety of stressful conditions, including (but not limited to) nutritional, hormonal, chemical and physical cues 188 . Although autophagy has long been considered as a form of regulated cell death (rCD), it is now well established that autophagy most often mediates cytoprotective effects, especially in mammals. Accordingly, pharmacological or genetic inhibition of autophagy generally sensitizes mammalian cells to rCD driven by stress 10 . Thus, at odds with other intracellular mechanisms of adaptation to stress, autophagy does not actively drive RCD if cellular homeostasis cannot be recovered, at least in the majority of settings. inhibitor, acyl-CoA-binding protein (DBI) 116 , as well as other cytoplasmic components 117 . The secretion of mature IL-1β (which is produced by the inflammasome) may involve the uptake of the protein by autophagosomes, most likely between the inner and the outer membrane of the organelle (which explains why the protein is not degraded) 118 . This process relies on heat shock protein HSP90α, which binds two KFERQ-like motifs of IL-1β (REF.
118
) and culminates with the fusion between autophagosomes and the plasma membrane 119 , resulting in IL-1β secretion. However, autophagy also limits IL-1β production by multiple mechanisms, including the disposal of damaged mitochondria (which are endo genous sources of inflammasome activators; see above) via mitophagy 97, 98 , the degradation of assembled inflammasomes 120 and the catabolism of immature IL-1β 121 . Thus, although autophagy-dependent secretion supports the establishment of local inflammation, degradative autophagic responses quench it. Accordingly, induction of autophagy by caloric restriction or pharmacological stimuli dampens inflammation along with the reduction of extracellular cytokines including IL-1β, IL-6 and TNF 122 . In addition, IL-10 can promote degradative autophagy in macrophages, hence limiting IL-1β secretion (which, at least in part, contributes to the antiinflammatory effects of IL-10) 123 . Finally, induction of mitophagy can stimulate the conversion of macrophages towards a pro-inflammatory phenotype 124 . Thus, induction of autophagy may mediate anti-inflammatory or pro-inflammatory effects depending on the context. Of note, protein secretion by autophagy can also operate as a salvage pathway when the conventional secretory pathways fail. For instance, the release of lysozyme (an antibacterial molecule) by Paneth cells infected with Salmonella enterica subsp. enterica serovar Typhimurium relies on autophagy because conventional secretion is blocked by bacterial products 125 . This pathway is compromised by mutations in the autophagy-relevant gene ATG16L1 that are associated with an increased risk of Crohn's disease 125 . Altogether, these examples illustrate how induction of autophagy in one cell may result in the emission of signals that affect other cells locally and systemically. At least in some settings, the paracrine and endocrine effects of autophagy appear to depend on whether autophagic responses are successful (and stressed cells are able to recover homeostasis) or not (and stressed cells succumb to RCD). Most likely, this reflects the differential secretion of other signals (for example, metabolites, cytokines and so forth) that influence the interface between the intracellular and extracellular outputs of autophagy. Identifying the signals that are differentially released from cells undergoing successful versus unsuccessful autophagic responses will provide important insights into non-cell-autonomous roles of autophagy.
Failing adaptation to cellular stress Prolonged or severe perturbations of homeostasis that cannot be managed by adaptive mechanisms generally culminate with the proliferative inactivation (cellular senescence) or elimination (via RCD) of stressed cells.
Both of these processes influence the maintenance of organismal homeostasis, both directly and via paracrine and endocrine mechanisms. Cellular senescence. Cellular senescence is a stress response activated by DNA damage to degrees that are irreparable but insufficient to drive RCD, oncogene signalling or other potential threats to organismal homeostasis 9 . Characteristics of senescence include a permanent proliferative arrest linked to the expression of cell cycle inhibitors such as cyclin-dependent kinase inhibitor 2A (CDKN2A) and CDKN1A; a profound metabolic reprogramming often involving autophagy activation; and the secretion of multiple bioactive factors including cytokines, chemokines and extracellular matrix proteins such as IL-1α, IL-6, IL-8, insulin-like growth factor-binding protein 7 (IGFBP7), transforming growth factor-β1 (TGFβ1) and others 9 . The latter property is referred to as senescenceassociated secretory phenotype (SASP) and results from the activation of kinases including MAPK14 and mTOR, epigenetic modifiers such as lysine N-methyltransferase 2A (encoded by KMT2A) and transcription factors including NF-κB, C/EBPβ, GATA-binding factor 4 (GATA4) and bromodomain-containing protein 4 (BRD4) 126 . Multiple subtypes of the SASP, differing in the composition of factors that are released, have been charac terized 127 . Importantly, a substantial fraction of the SASP-associated secretome is generated by the shedding of membrane-anchored proteins and domains thereof, resulting from the expression of the metalloproteinase ADAM17 (REF.
128
). The SASP constitutes a major mechanism whereby cellular senescence is relayed to the local and systemic micro environment and thus has major pathophysiological and therapeutic relevance.
Cytosolic DNA accumulation resulting in cGAS-STING-dependent type I IFN secretion is intimately associated with the establishment of senescence and the SASP (although cGAS-STING activation does not invariably trigger senescence) 23, 129 . Thus, cGAS-deficient or STING-deficient mouse embryonic fibroblasts (MEFs) are resistant to senescence induction and largely deficient in the secretion of IL-6 and CXC-motif chemokine ligand 10 (CXCL10) 129 . Indeed, STING not only mediates type I IFN production via IRF3 (REF. 130 ) but also triggers NF-κB activation via TANK-binding kinase 1 (TBK1) 131 . Importantly, type I IFN is sufficient to trigger senescence in both wild-type and cGAS-deficient MEFs, and MEFs lacking IFNα/β receptor 1 (IFNAR1) resist oxidative stress-induced senescence. Thus, type I IFN may mediate the autocrine and paracrine propagation of cellular senescence 129, 132 . This observation echoes prior reports showing that IL-1α, IL-6, IL-8, IGFB7 and CXCL1 contribute to the autocrine and paracrine maintenance of the senescent phenotype [133] [134] [135] . Overall, different components of the SASP can participate in the establishment and perpetuation of senescence as they regulate the local inflammatory milieu. Of note, senescent cells also release increased amounts of exosomes and similar extracellular vesicles that can serve as vessels for diverse cargoes, including proteins, signalling molecules and RNAs
136
.
Pro-opiomelanocortin neurons
Hypothalamic neurons capable of synthesizing proopiomelanocortin (PoMC), the precursor of circulating melanocyte stimulating hormone, adrenocorticotropin hormone and β-endorphin
Non-conventional secretion
Process through which intracellular proteins and other cytoplasmic components are released into the extracellular milieu independently of the endoplasmic reticulum and golgi apparatus.
Paneth cells
Cells from the intestinal epithelium that contribute to the maintenance of the gastrointestinal barrier.
Crohn's disease
Chronic inflammatory condition of the gastrointestinal tract associated with an increased risk of colorectal cancer.
Exosomes
Cell-derived small vesicles that are present in virtually all mammalian fluids, including blood and urine.
Senescence is tightly linked to ageing, as senescent cells accumulate with age and have been proposed to support ageing by a variety of mechanisms 137 . Accordingly, systemic elimination of senescent cells upon pharmacological activation of apoptosis (in the context of genetic modifications that enable the specific targeting of senescent cells) or upon administration of senolytic drugs has broad anti-ageing and even rejuvenating effects, at least in preclinical models [138] [139] [140] . The current literature suggests a critical pathophysiological role of the SASP in ageing. For example, culture media conditioned by senescent cells increase the osteolytic function of osteoclasts and inhibit bone mineralization by osteoblasts in vitro, in line with the fact that elimination of senescent cells by genetic methods or senolytic drugs improves bone architecture and strength in aged mice 141 . Notably, inhibition of the production of several SASP components was sufficient to counteract bone frailty and age-related bone loss in mice [141] [142] [143] . However, it remains to be determined to what extent the anti-ageing effects of senolysis stem from the suppression of SASP. Epistatic experiments testing the elimination of senescent cells in the presence versus the absence of SASP inhibitors might resolve this issue.
Senescence not only is a maladaptive process that accompanies and aggravates ageing but also is a contributor to the maintenance of local and systemic homeostasis. One important role of senescent cells is promoting tissue regeneration, which can occur through secretion of extracellular-matrix-modifying proteases, growthpromoting and stem cell-activating factors and chemoattractants for immune cells 144 Accordingly, senescent fibroblasts and endothelial cells promote the differentiation of myofibroblasts by secreting platelet-derived growth factor A (PDGFA), and eliminating such senescent cells delays skin wound healing 145 . Furthermore, as mentioned above, senescent cells are recognized and can be removed by NK cells and other lymphocytes. This phenomenon, known as senescence surveillance, reportedly prevents tumorigenesis driven by pre-malignant or malignant hepatocytes 20 . In addition, induction of senescence in hepatocellular carcinoma cells upon restoration of TP53 expression promotes tumour clearance 146 . In this case, p53 is responsible for the secretion of chemokines such as CC-motif chemokine ligand 2 (CCL2) that attract NK cells and hence enable tumour rejection 146 ( Fig. 4a) . Notably, although tumour rejection depends on NKG2D in this setting, induction of senescence by TP53 expression did not promote the expression of NKG2D ligands, suggesting that other mechanisms are at play.
Overall, it is clear that induction of senescence has important consequences for human pathophysiology. In particular, senescence has long been viewed as an ac ceptable therapeutic goal for cancer therapy, reflecting the permanent proliferative inactivation associated with the senescent state 144 . However, senescence has also been shown to promote tumour progression and resistance to therapy, mostly reflecting the ability of senescent cells to release a number of soluble factors that support cancer cell proliferation and remodel the extracellular matrix 144 . For example, senescent cells can produce exosome-like vesicles containing high levels of ephrin type A receptor 2 (EPHA2), which support tumour progression upon binding to ephrin A1 (EFNA1) on the surface of malignant cells 147 . The extensive intratumoural heterogeneity that characterizes most human neoplasms 22 may also contribute to the different responses mediated by senescent cells in the tumour microenvironment.
Regulated cell death.
The links between RCD and systemic homeostasis are multiple and tightly regulated. Programmed cell death (PCD) culminates with efficient removal of cell corpses by tissue-resident macrophages coupled with the delivery of robust anti-inflammatory signals 148, 149 . Conversely, RCD occurring in the context of failing adaptation to stress can be linked to the release of cellular content, including various pro-inflammatory signals 150 . The pro-inflammatory effects of RCD can underlie pathogenic maladaptation, as in the case of systemic lupus erythematosus (SLE) 150 . In the course of both PCD and stress-induced RCD, molecules that are exposed on the surface of dying cells or released from them relay RCD to the local (and potentially even systemic) microenvironment. The ultimate outcome of stress-induced RCD largely depends on the precise molecular mechanism of RCD that is engaged, the extent of cell death and the local proficiency of the phagocytic system. PCD is often immunologically silent. This form of RCD is generally precipitated by apoptotic caspases, notably CASP3 (REF. 10 ), and the activation of CASP3 in dying cells is linked to a variety of anti-inflammatory effects. For instance, CASP3 efficiently prevents cGAS-STING-dependent type I IFN production upon MOMP 94, 95 and is responsible for the production of the mitogenic and immunosuppressive factor prostaglandin E 2 (PGE 2 ) 151, 152 . Moreover, CASP3 underlies the exposure of phosphatidylserine (PtdSer) on the surface of dying cells 153, 154 , which delivers robust antiinflammatory signals to macrophages 155, 156 (Fig. 4b) . In line with this notion, Jmjd6 −/− mice (which lack the PtdSer receptor) die at birth owing to a robust inflammatory response driven by the accumulation of dead cells in the brain and lungs 155, 156 . Similarly, Rubcn −/− mice (which are deficient in LC3-associated phagocytosis) spontaneously develop an SLE-like disorder resulting from the accumulation of dead cells 157 . These observations suggest that apoptosis evolved after other RCD modalities as a means to control RCD-driven inflammation, which is of particular importance for embryonic development and adult tissue homeostasis.
In contrast to cells dying by PCD, cells that undergo RCD as a consequence of failing adaptation to stress can be highly immunogenic. These cells secrete a number of damage-associated molecular patterns (DAMPs), which include (but are not limited to) cytokines such as IL-1β, type I IFN and CXCL10; metabolic intermediates such as ATP, uric acid and oxidized phospholipids; nucleic acids; nuclear and cytosolic proteins that are normally not secreted, such as high mobility group protein B1 (HMGB1), annexin A1 (ANXA1) and F-actin; and ER chaperones such as CALR and HSP70 (reviewed in REF. 17 ). IL-1β and type I IFN favour the establishment of local inflammation, whereas CXCL10 operates as a chemoattractant for T lymphocytes 158 . Extracellular ATP has multipronged effects on the local
Senolytic drugs
Agents that selectively kill senescent cells.
Programmed cell death
(PCD). Purely physiological variant of regulated cell death that contributes to postembryonic or embryonic development as well as to the maintenance of adult tissue homeostasis.
Systemic lupus erythematosus
(sLE). Mild to severe autoimmune disease affecting a variety of tissues, including joints, skin, heart and lungs.
LC3-associated phagocytosis
specific variant of the phagocytic process that relies on multiple, but not all, components of the molecular apparatus for autophagy.
Damage-associated molecular patterns (DAMPs). Endogenous molecules that, upon exposure on the plasma membrane or secretion, can be recognized by a pattern recognition receptor and hence participate in the regulation of inflammatory responses.
volume 19 | november 2018 | 741 microenvironment, including chemotactic and activatory effects on dendritic cells 17 and its ability to induce cell death through pyroptosis (which is associated with inflammasome activation and IL-1β production; see also below) 159 . Both urate and oxidized phospholipids can trigger inflammasome activation in living myeloid cells 160 , whereas nucleic acids can be recognized by a plethora of pattern recognition receptors, including Toll-like receptor 3 (TLR3), TLR9, cGAS, absent in melanoma 2 (AIM2) and multiple Rigi-like receptors (RLRs), resulting in myeloid cell activation 159 . HGMB1 also mediates immunostimulatory effects upon binding to advanced glycosylation end product-specific receptor (AGER) and TLR4, as does F-actin upon binding to C-type lectin domain family 4 (CLEC4) 17 . ANXA1 mainly operates to guide the approach of myeloid cells to dying cells via N-formyl peptide receptor 1 (FPR1) 161 . Finally, ER chaperones, upon binding to multiple receptors, also act as phagocytic signals 17 . Thus, cells that are eliminated through RCD are capable of releasing various immune stimulating and pro-inflammatory signals. The type of cell death influences -quantitatively, qualitatively and kinetically -the release of these signals.
Pyroptosis generally involves the activation of CASP1, resulting in the proteolytic maturation and release of IL-1β and IL-18 and in the formation of gasdermin D (GSDMD) pores that mediate rapid plasma membrane permeabilization and hence allow for massive DAMP release 162 . In response to specific bacterial components (lipopolysaccharide and lipid A), GSDMD can also be activated by CASP4, CASP5 or CASP11, resulting in pyroptotic cell death without IL-1β secretion 163 . In addition, in cells treated with certain chemotherapeutics (such as doxorubicin or etoposide), pyroptotic cell death may be induced as a secondary effect of the apoptotic cascade. In this case, pro-apoptotic CASP3
Pyroptosis
Variant of regulated cell death that is associated with the formation of pores in the plasma membrane by one of multiple gasdermin family members. senescence, which often occurs as a consequence of sublethal DNA damage, is associated with a broad transcriptional reprogramming that involves p53-dependent as well as p53-independent programmes. Among other consequences, this reprogramming enables the secretion of multiple cytokines and bioactive factors that constitute the so-called 'senescence-associated secretory phenotype' (SASP), including (but not limited to) interferon-β1 (IFNβ1), interleukin-6 (IL-6), IL-8 and CC-motif chemokine ligand 2 (CCL2). In conjunction, the activation of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related protein (ATR) at sites of DNA damage can drive the exposure of natural killer (NK) cell-activating ligands (NKALs) on the cell surface. Collectively , these processes support the eradication of senescent cells by lymphoid cells, a process that is commonly referred to as senescence surveillance. b | Ligation of FAS cell surface death receptor by FAS ligand (FASLG) initiates a lethal sequence of events that culminates with mitochondrial outer membrane permeabilization (MOMP) and caspase 3 (CASP3) activation, eventually driving apoptotic cell death. CASP3 not only favours the translocation of phosphatidylserine (PtdSer) from the inner (PtdSer i ) to the outer leaflet (PtdSer e ) of the plasma membrane but also stimulates the secretion of prostaglandin E 2 (PGE 2 ), two processes that reduce the immunostimulatory potential of dying cells. CASP3 also suppresses the activation of cyclic GMP-AMP synthase (cGAS) signalling in response to the MOMP-dependent release of double-stranded DNA (dsDNA) in the cytosol, thereby preventing the secretion of type I interferon (IFN) and the consequent establishment of local inflammation. ATP11C, ATPase phospholipid transporting 11C; BID, BH3-interacting domain death agonist; CHK , checkpoint kinase; CCR2, CC-motif chemokine receptor 2; CYCS, cytochrome c, somatic; EP, PGE 2 receptor EP subtype; IFNAR , IFNα/β receptor ; IRF3, interferon regulatory factor 3; JMJD6, Jumonji domain-containing 6, arginine demethylase and lysyl hydroxylase; NKG2D, NKG2D type II integral membrane protein; PL A2G6, phospholipase A2 group VI; RCD, regulated cell death; STING stimulator of interferon genes; XKR8, XK-related 8. activates another member of the gasdermin family, GSDME, which drives cell lysis in the absence of IL-1β secretion. This RCD modality may be linked to the side effects of chemotherapy on normal tissues, as cancer cells often express low GSDME levels 164 . Overall, as it is linked to pro-inflammatory cytokine secretion, pyroptosis is inherently immunogenic. In addition, even in the absence of inflammasome activation, formation of gasdermin-based channels during pyroptotic cell death is invariably related to the abundant release of cellular DAMPs into the microenvironment.
RIGI-like receptors
Whereas 'accidental' necrosis can mediate immunosuppressive effects by promoting the accumulation of K + ions in the microenvironment of dying cells and consequent T cell inhibition 165 , the molecular machinery driving RCD via necroptosis can exert immunostimulatory functions 166, 167 . The main transducers of proinflammatory signals during necroptosis are receptor interacting serine/threonine-protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL), two core components of the necroptotic machinery. Both RIPK3 and MLKL are capable of stimulating inflammasome activation and consequent IL-1β, ATP, HGMB1 and type I IFN release, and both are required for the immuno genicity of RCD driven by some chemotherapeutic agents such as anthracyclines and oxaliplatin [168] [169] [170] . Moreover, chemical dimerization of RIPK3 favours the activation of an NF-κB-dependent transcriptional programme (involving IL-6 and CXCL1 secretion) that in some 171 , but not all 172 , models contributes to the immuno genicity of necroptosis. The reasons underlying this discrepancy remain to be elucidated but may relate to context-dependent variables affecting the NF-κB-dependent secretome, such as cell type, necroptosisinducing stimuli and microenvironmental parameters. Additional work is required to clarify this issue.
As mentioned above, apoptotic PCD is usually immunologically silent 1 . However, in response to certain stimuli, including anthracyclines, oxaliplatin and hypofractionated irradiation, apoptosis can mediate robust immunostimulatory effects 17, 173 . Such a form of immunogenic cell death (ICD) mechanistically relies on the activation of intracellular stress responses, including (but perhaps not limited to) a partial ER stress response (culminating in the exposure of pro-phagocytic signals; see above) 63 , autophagy (resulting in ATP release; see above) 110 and intracellular nucleic acid sensing (resulting in type I IFN release, see above) 25, 174 . Interestingly, apoptotic ICD depends on CASP8 (REF. 64 ), although it seems that the activation of the pro-inflammatory NF-κB pathway in the course of RCD is robustly inhibited by caspases 175 . Thus, apoptotic ICD stands out as a functionally defined form of RCD that involves caspase activation in the absence of caspase-dependent immunosuppression 176 . Of note, ICD appears to be extremely relevant for cancer therapy as it has been consistently associated with the success of treatment beyond its discontinuation, most likely by participating in the establishment of a clinically useful tumour-targeting immune response 161, 174, 177 . Taken together, these observations suggest that RCD induced in response to irreparable damage signals has a major influence on local and systemic inflammatory homeostasis. Such a link stands out as a promising therapeutic target for the management of multiple pathologies in which the unwarranted loss of postmitotic cells is coupled to a pathogenic inflammatory reaction, such as cardiac infarction or neuronal ischaemia 178 , as well as for cancer treatment, in which the activation of tumourtargeting immune responses has become a common therapeutic goal 17 .
Conclusions and perspectives
In summary, mammalian cells react to potentially harmful perturbations of their microenvironment either by adaptation and damage repair or by irreversible inactiv ation (via senescence or RCD), and both of these responses are linked to a complex network of signals that connect individual cells to the tissue and the whole organism. Globally, these signals influence a large panel of processes, ranging from local inflammatory reactions to whole-body metabolic homeostasis and feeding behaviour, and their deregulated emission has been linked to multiple pathologies.
It is tempting to speculate that the mechanisms bridging cellular stress responses to the environment (be they local, systemic or interindividual) were established early in the evolution of multicellular life, mostly likely along with the establishment of colonial behaviour. In support of this notion, yeast cells release Acb1 (the orthologue of mammalian DBI) in response to carbon shortage, and extracellular Acb1 reportedly regulates specific colonial activities in a paracrine manner 179 . Of note, many instances of intracellular response to stress in lower eukaryotes (for example, C. elegans) have been directly linked to systemic homeostasis via endocrine mechanisms. Conversely, cellular responses to stress in mammals have been mostly connected to local circuitries impinging on autocrine and/or paracrine signalling or the regulation of inflammatory responses at the microenvironmental level, with a few exceptions 13, 53 . We surmise that such an apparent discrepancy in the general organization of organismal stress responses in lower versus higher eukaryotes may largely reflect the different degree of complexity of these organisms.
The paracrine and endocrine pathways elicited by cellular stress have major implications for the treatment of a large panel of human disorders. On the one hand, it has become clear that preventing RCD in ischaemic tissues is generally not achievable. Thus, considerable attention is being devoted to strategies that may modulate the ability of RCD to establish local inflammation rather than the occurrence of RCD itself 178 . On the other hand, it is now established that the activation of tumourtargeting immune responses by anticancer therapy is responsible for the long-term success of treatment. Thus, anticancer therapies are now being aimed at specifically provoking ICD rather than causing a large cytotoxic effect 113 . We suspect that additional mechanisms that relay adaptation to stress from individual cells to the whole organism will be elucidated in the near future, and this will likely change our perception of many other pathophysiological processes. 
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